Insider Trading activities of Acorda Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acorda Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acorda Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Acorda Therapeutics Inc since 2005. The reporting company's ticker symbol is ACOR. The reporting company's CIK number is 1008848.
The total value of stock buying since 2005 is $17,199,472.
The total value of stock sales since 2005 is $127,471,877.
The total value of stock option exercises since 2005 is $17,127,161.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Acorda Therapeutics Inc (ACOR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 250 $6,350 0 $0
2017-08 766,201 $14,860,468 20,000 $431,400 20,000 $364,200
2017-07 0 $0 10,000 $216,620 10,000 $182,100
2017-06 20,000 $339,000 0 $0 0 $0
2017-05 0 $0 7,704 $121,322 0 $0
2017-02 0 $0 186,028 $4,157,541 186,028 $4,116,797
2017-01 0 $0 3,017 $58,113 3,017 $48,000
2016-12 0 $0 40,172 $845,540 40,172 $622,264
2016-10 0 $0 6,063 $125,009 0 $0
2016-09 0 $0 500 $13,660 500 $4,250
2016-08 0 $0 0 $0 9,754 $215,856
2016-06 0 $0 1,586 $42,769 10,233 $215,861
2016-05 0 $0 4,860 $126,884 0 $0
2016-04 0 $0 1,488 $42,675 1,488 $27,751
2016-02 0 $0 0 $0 29,238 $266,445
2016-01 0 $0 13,231 $556,403 13,231 $256,641
2015-12 0 $0 129,280 $5,211,130 79,738 $815,837
2015-11 0 $0 500 $18,735 17,322 $103,920
2015-10 0 $0 177,200 $5,088,154 167,500 $1,405,666
2015-09 0 $0 13,085 $409,953 13,085 $78,510
2015-05 0 $0 4,779 $142,494 0 $0
2015-03 0 $0 2,698 $94,179 2,698 $21,961
2015-01 0 $0 107,993 $4,578,137 107,993 $2,780,932
2014-12 0 $0 103,129 $3,862,079 98,374 $1,121,463
2014-11 0 $0 14,923 $519,947 14,923 $121,473
2014-10 0 $0 65,371 $2,107,583 52,338 $426,031
2014-09 0 $0 14,923 $537,228 14,923 $121,473
2014-08 0 $0 14,923 $492,459 14,923 $121,473
2013-12 0 $0 63,514 $2,113,770 0 $0
2013-11 0 $0 10,949 $369,211 0 $0
2013-10 0 $0 7,083 $241,929 0 $0
2013-08 0 $0 164,000 $5,656,651 304,778 $1,004,520
2013-07 0 $0 19,296 $729,774 19,296 $50,169
2013-06 0 $0 11,000 $375,650 0 $0
2013-05 0 $0 10,000 $338,000 10,000 $254,500
2012-12 0 $0 45,103 $1,093,820 1 $5
2012-11 0 $0 32,767 $796,151 32,767 $453,324
2012-10 0 $0 12,581 $291,826 9,481 $24,650
2011-12 0 $0 45,104 $1,033,739 0 $0
2011-06 0 $0 12,000 $370,440 0 $0
2011-05 0 $0 62,500 $2,033,800 62,500 $171,000
2011-04 0 $0 60,000 $1,694,400 60,000 $156,000
2011-03 0 $0 129,055 $2,735,584 0 $0
2011-01 0 $0 5,000 $150,000 5,000 $30,000
2010-12 0 $0 37,338 $993,808 0 $0
2010-08 0 $0 305,000 $10,971,819 108,696 $465,809
2010-06 0 $0 8,397 $285,498 0 $0
2010-03 0 $0 122,567 $4,148,962 50,000 $196,480
2010-02 0 $0 9,534 $286,020 5,000 $40,700
2010-01 0 $0 5,000 $140,000 5,000 $40,700
2009-12 0 $0 30,466 $746,455 5,000 $40,700
2009-08 0 $0 10,000 $235,799 10,000 $60,000
2009-02 0 $0 51,923 $1,230,159 1,923 $4,999
2008-12 0 $0 10,634 $171,886 0 $0
2008-09 0 $0 74,537 $2,158,402 25,000 $65,000
2008-07 0 $0 36,900 $1,155,230 25,000 $65,000
2008-06 0 $0 482,612 $14,881,585 141,390 $487,304
2008-05 0 $0 2,425 $46,458 0 $0
2008-04 0 $0 3,586 $65,953 0 $0
2008-03 0 $0 19,400 $347,850 0 $0
2008-02 0 $0 106,912 $2,333,652 4,487 $11,666
2008-01 0 $0 714,118 $18,313,989 7,000 $18,200
2007-12 0 $0 24,332 $515,873 7,000 $18,200
2007-11 0 $0 9,293 $169,851 0 $0
2007-10 0 $0 6,795 $137,162 4,487 $11,666
2007-09 0 $0 18,440 $308,782 0 $0
2007-08 0 $0 131,942 $2,269,331 6,410 $16,666
2007-07 0 $0 7,500 $132,690 0 $0
2007-06 0 $0 156,755 $2,914,373 0 $0
2007-05 0 $0 10,983 $267,899 0 $0
2007-04 0 $0 8,383 $164,883 0 $0
2007-03 0 $0 25,323 $506,907 0 $0
2007-02 0 $0 24,719 $530,727 0 $0
2007-01 0 $0 20,141 $326,571 0 $0
2006-12 0 $0 24,897 $445,665 641 $999
2006-11 0 $0 293,896 $4,787,520 0 $0
2006-10 0 $0 346,002 $5,649,009 0 $0
2006-02 333,334 $2,000,004 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Acorda Therapeutics Inc insiders (ACOR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-09 Lawrence David (Chief, Bus. Ops & PAO) Sale 250 25.40 6,350
2017-08-29 Mindich Jeremy (10% Owner) Buy 766,201 19.39 14,860,468
2017-08-01 Greene Barry E (Director) Sale 10,000 21.57 215,700
2017-08-01 Greene Barry E (Director) Option Ex 10,000 18.21 182,100
2017-08-01 Rauscher Steven M (Director) Sale 10,000 21.57 215,700
2017-08-01 Rauscher Steven M (Director) Option Ex 10,000 18.21 182,100
2017-07-31 Randall Lorin (Director) Sale 10,000 21.66 216,620
2017-07-31 Randall Lorin (Director) Option Ex 10,000 18.21 182,100
2017-06-16 Cohen Ron (President and CEO) Buy 20,000 16.95 339,000
2017-05-15 Hindman Andrew A. (Chief Business Dev. Officer) Sale 7,704 15.75 121,322
2017-02-09 Wasman Jane (President, Intl and GC) Sale 54,536 22.30 1,216,207
2017-02-09 Wasman Jane (President, Intl and GC) Option Ex 54,536 22.13 1,206,881
2017-02-09 Blight Andrew (Chief Scientific Officer) Sale 67,586 22.41 1,514,399
2017-02-09 Blight Andrew (Chief Scientific Officer) Option Ex 67,586 22.13 1,495,678
2017-02-09 Greene Barry E (Director) Sale 723 22.65 16,375
2017-02-09 Greene Barry E (Director) Option Ex 723 22.13 15,999
2017-02-09 Lawrence David (Chief, Bus. Ops & PAO) Sale 63,183 22.32 1,410,560
2017-02-09 Lawrence David (Chief, Bus. Ops & PAO) Option Ex 63,183 22.13 1,398,239
2017-01-03 Greene Barry E (Director) Sale 3,017 19.26 58,113
2017-01-03 Greene Barry E (Director) Option Ex 3,017 15.91 48,000
2016-12-14 Cohen Ron (President and CEO) Sale 40,172 21.05 845,540
2016-12-14 Cohen Ron (President and CEO) Option Ex 40,172 15.49 622,264
2016-10-21 Batycky Richard P. (Chief Tech. Off. & Site Head) Sale 2,063 20.30 41,876
2016-10-07 Lawrence David (Chief, Bus. Ops & PAO) Sale 250 20.82 5,205
2016-10-03 Wasman Jane (President, Intl and GC) Sale 3,750 20.78 77,928
2016-09-23 Wasman Jane (President, Intl and GC) Sale 500 27.32 13,660
2016-09-23 Wasman Jane (President, Intl and GC) Option Ex 500 8.50 4,250
2016-08-09 Blight Andrew (Chief Scientific Officer) Option Ex 9,754 22.13 215,856
2016-06-22 Lawrence David (Chief of Business Operations) Sale 500 25.09 12,545
2016-06-22 Lawrence David (Chief of Business Operations) Option Ex 500 8.50 4,250
2016-06-10 Wasman Jane (President, Intl and GC) Option Ex 8,647 22.13 191,358
2016-06-08 Rauscher Steven M (Director) Sale 1,086 27.83 30,224
2016-06-08 Rauscher Steven M (Director) Option Ex 1,086 18.65 20,253
2016-05-13 Hindman Andrew A. (Chief Business Dev. Officer) Sale 4,860 26.11 126,884
2016-04-19 Randall Lorin (Director) Sale 1,488 28.68 42,675
2016-04-19 Randall Lorin (Director) Option Ex 1,488 18.65 27,751
2016-02-04 Cohen Ron (President and CEO) Option Ex 29,238 9.11 266,445
2016-01-04 Smith Ian F (Director) Sale 13,231 42.05 556,403
2016-01-04 Smith Ian F (Director) Option Ex 13,231 19.40 256,641
2015-12-23 Wasman Jane (President, Intl and GC) Sale 10,751 43.10 463,400
2015-12-23 Wasman Jane (President, Intl and GC) Option Ex 10,751 5.85 62,893
2015-12-22 Sabella Lauren M (Chief Commercial Officer) Sale 7,113 42.05 299,066
2015-12-22 Sabella Lauren M (Chief Commercial Officer) Option Ex 7,113 22.06 156,912
2015-12-22 Wasman Jane (President, Intl and GC) Sale 13,797 42.54 586,869
2015-12-22 Wasman Jane (President, Intl and GC) Option Ex 5,342 5.85 31,250
2015-12-21 Wasman Jane (President, Intl and GC) Sale 817 42.00 34,314
2015-12-18 Lawrence David (Chief of Business Operations) Sale 39,026 40.84 1,593,821
2015-12-18 Lawrence David (Chief of Business Operations) Option Ex 39,026 5.92 231,229
2015-12-17 Sabella Lauren M (Chief Commercial Officer) Sale 14,229 40.00 569,160
2015-12-17 Sabella Lauren M (Chief Commercial Officer) Option Ex 14,229 22.06 313,891
2015-12-17 Wasman Jane (President, Intl and GC) Sale 3,277 40.00 131,080
2015-12-17 Wasman Jane (President, Intl and GC) Option Ex 3,277 6.00 19,662
2015-12-01 Hindman Andrew A. (Chief Business Dev. Officer) Sale 442 38.26 16,910
2015-12-01 Carrazana Enrique J. (Chief Medical Officer) Sale 7,218 38.08 274,868
2015-12-01 Sabella Lauren M (Chief Commercial Officer) Sale 7,106 38.06 270,482
2015-12-01 Wasman Jane (President, Intl and GC) Sale 5,523 38.08 210,293
2015-12-01 Cohen Ron (President and CEO) Sale 11,850 38.08 451,224
2015-12-01 Lawrence David (Chief of Business Operations) Sale 7,167 38.09 272,955
2015-12-01 Rogers Michael W (Chief Financial Officer) Sale 964 38.06 36,688
2015-11-20 Blight Andrew (Chief Scientific Officer) Sale 500 37.47 18,735
2015-11-20 Blight Andrew (Chief Scientific Officer) Option Ex 500 8.50 4,250
2015-11-04 Wasman Jane (President, Intl and GC) Option Ex 16,822 5.92 99,670
2015-10-19 Blight Andrew (Chief Scientifc Officer) Sale 32,500 31.03 1,008,540
2015-10-19 Blight Andrew (Chief Scientifc Officer) Option Ex 32,500 5.85 190,125
2015-10-07 Lawrence David (Chief of Business Operations) Sale 250 29.82 7,455
2015-10-07 Rogers Michael W (Chief Financial Officer) Sale 5,700 29.98 170,886
2015-10-05 Wasman Jane (President, Intl and GC) Sale 3,750 31.40 117,753
2015-10-05 Cohen Ron (President and CEO) Sale 910 30.10 27,391
2015-10-05 Cohen Ron (President and CEO) Option Ex 910 15.49 14,095
2015-10-02 Cohen Ron (President and CEO) Sale 134,090 28.01 3,756,129
2015-10-02 Cohen Ron (President and CEO) Option Ex 134,090 8.96 1,201,446
2015-09-21 Blight Andrew (Chief Scientifc Officer) Sale 13,085 31.33 409,953
2015-09-21 Blight Andrew (Chief Scientifc Officer) Option Ex 13,085 6.00 78,510
2015-05-15 Hindman Andrew A. (Chief Business Dev. Officer) Sale 475 30.16 14,326
2015-05-13 Hindman Andrew A. (Chief Business Dev. Officer) Sale 4,304 29.78 128,168
2015-03-04 Rauscher Steven M (Director) Sale 2,698 34.91 94,179
2015-03-04 Rauscher Steven M (Director) Option Ex 2,698 8.14 21,961
2015-01-13 Kelley John P (Director) Sale 10,000 44.00 440,000
2015-01-13 Kelley John P (Director) Option Ex 10,000 25.45 254,500
2015-01-12 Carrazana Enrique J. (Chief Medical Officer) Sale 13,371 43.06 575,715
2015-01-12 Carrazana Enrique J. (Chief Medical Officer) Option Ex 13,371 21.52 287,743
2015-01-09 Carrazana Enrique J. (Chief Medical Officer) Sale 77,907 42.11 3,280,352
2015-01-09 Carrazana Enrique J. (Chief Medical Officer) Option Ex 77,907 26.11 2,034,151
2015-01-08 Carrazana Enrique J. (Chief Medical Officer) Sale 6,715 42.01 282,070
2015-01-08 Carrazana Enrique J. (Chief Medical Officer) Option Ex 6,715 30.46 204,538
2014-12-18 Kelley John P (Director) Sale 10,000 40.00 400,000
2014-12-18 Kelley John P (Director) Option Ex 10,000 16.74 167,399
2014-12-18 Lawrence David (Chief of Business Operations) Sale 27,109 40.11 1,087,396
2014-12-18 Lawrence David (Chief of Business Operations) Option Ex 27,109 8.14 220,667
2014-12-12 Panem Sandra Phd (Director) Sale 10,000 38.10 381,000
2014-12-12 Panem Sandra Phd (Director) Option Ex 10,000 31.61 316,100
2014-12-01 Carrazana Enrique J. (Chief Medical Officer) Sale 2,300 35.55 81,774
2014-12-01 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 3,242 35.58 115,343
2014-12-01 Wasman Jane (President, Intl and GC) Sale 6,956 35.58 247,473
2014-12-01 Cohen Ron (President and CEO) Sale 34,394 35.59 1,224,151
2014-12-01 Cohen Ron (President and CEO) Option Ex 51,265 8.14 417,297
2014-12-01 Lawrence David (Chief of Business Operations) Sale 8,898 35.60 316,759
2014-12-01 Rogers Michael W (Chief Financial Officer) Sale 230 35.58 8,183
2014-11-03 Wasman Jane (President, Intl and GC) Sale 14,923 34.84 519,947
2014-11-03 Wasman Jane (President, Intl and GC) Option Ex 14,923 8.14 121,473
2014-10-20 Blight Andrew (Chief Scientifc Officer) Sale 52,338 32.08 1,678,793
2014-10-20 Blight Andrew (Chief Scientifc Officer) Option Ex 52,338 8.14 426,031
2014-10-15 Carrazana Enrique J. (Chief Medical Officer) Sale 3,333 31.13 103,749
2014-10-07 Lawrence David (Chief of Business Operations) Sale 250 33.60 8,400
2014-10-07 Rogers Michael W (Chief Financial Officer) Sale 5,700 33.10 188,658
2014-10-03 Wasman Jane (President, Intl and GC) Sale 3,750 34.13 127,983
2014-09-24 Wasman Jane (President, Intl and GC) Sale 14,923 36.00 537,228
2014-09-24 Wasman Jane (President, Intl and GC) Option Ex 14,923 8.14 121,473
2014-08-27 Wasman Jane (President, Intl and GC) Sale 14,923 33.00 492,459
2014-08-27 Wasman Jane (President, Intl and GC) Option Ex 14,923 8.14 121,473
2013-12-05 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 8,797 31.81 279,832
2013-12-02 Carrazana Enrique J. (Chief Medical Officer) Sale 1,640 33.56 55,033
2013-12-02 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 6,603 33.52 221,319
2013-12-02 Wasman Jane (President, Intl and GC) Sale 8,425 33.52 282,397
2013-12-02 Blight Andrew (Chief Scientifc Officer) Sale 9,088 33.51 304,566
2013-12-02 Cohen Ron (President and CEO) Sale 18,125 33.52 607,477
2013-12-02 Lawrence David (Chief of Business Operations) Sale 10,836 33.51 363,146
2013-11-22 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 10,949 33.72 369,211
2013-10-15 Carrazana Enrique J. (Chief Medical Officer) Sale 3,333 32.38 107,919
2013-10-03 Wasman Jane (President, Intl and GC) Sale 3,750 35.74 134,010
2013-08-20 Cohen Ron (President and CEO) Sale 31,945 34.53 1,103,220
2013-08-20 Cohen Ron (President and CEO) Option Ex 172,723 2.60 449,079
2013-08-19 Cohen Ron (President and CEO) Sale 55,993 34.02 1,904,881
2013-08-19 Cohen Ron (President and CEO) Option Ex 55,993 2.60 145,581
2013-08-16 Cohen Ron (President and CEO) Sale 61,062 34.04 2,078,550
2013-08-16 Cohen Ron (President and CEO) Option Ex 61,062 2.60 158,761
2013-08-02 Kelley John P (Director) Sale 15,000 38.00 570,000
2013-08-02 Kelley John P (Director) Option Ex 15,000 16.74 251,099
2013-07-19 Blight Andrew (Chief Scientifc Officer) Sale 19,296 37.82 729,774
2013-07-19 Blight Andrew (Chief Scientifc Officer) Option Ex 19,296 2.60 50,169
2013-06-10 Cohen Ron (President and CEO) Sale 11,000 34.15 375,650
2013-05-08 Panem Sandra Phd (Director) Sale 10,000 33.80 338,000
2013-05-08 Panem Sandra Phd (Director) Option Ex 10,000 25.45 254,500
2012-12-07 Lawrence David (Chief Financial Officer) Option Ex 1 5.85 5
2012-12-04 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 4,364 24.58 107,258
2012-12-03 Carrazana Enrique J. (Chief Medical Officer) Sale 800 24.50 19,600
2012-12-03 Wasman Jane (President, Intl and GC) Sale 7,019 24.20 169,866
2012-12-03 Blight Andrew (Chief Scientifc Officer) Sale 7,200 24.20 174,247
2012-12-03 Cohen Ron (President and CEO) Sale 16,407 24.22 397,410
2012-12-03 Lawrence David (Chief Financial Officer) Sale 9,313 24.21 225,439
2012-11-28 Randall Lorin (Director) Sale 10,198 24.70 251,900
2012-11-28 Randall Lorin (Director) Option Ex 10,198 6.00 61,188
2012-11-13 Panem Sandra Phd (Director) Sale 22,569 24.11 544,251
2012-11-13 Panem Sandra Phd (Director) Option Ex 22,569 17.38 392,136
2012-10-22 Blight Andrew (Chief Scientifc Officer) Sale 9,481 23.08 218,821
2012-10-22 Blight Andrew (Chief Scientifc Officer) Option Ex 9,481 2.60 24,650
2012-10-16 Carrazana Enrique J. (Chief Medical Officer) Sale 3,100 23.55 73,005
2011-12-01 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 4,364 22.91 99,979
2011-12-01 Wasman Jane (Exec VP, General Counsel & Sec) Sale 7,344 22.92 168,324
2011-12-01 Blight Andrew (Chief Scientifc Officer) Sale 7,000 22.92 160,440
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ACOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acorda Therapeutics Inc (symbol ACOR, CIK number 1008848) see the Securities and Exchange Commission (SEC) website.